Association of 5’AMP-activated protein kinase activity with disease duration and HbA1c content in leukocytes in diabetic patients
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 1
Abstract
Background. 5’AMP-activated protein kinase (AMPK) is an enzyme that controls the cell energy balance. With energetic stress in the cell and an increase in the AMP concentration, ATP is replaced by AMP in the exchange centers, resulting in the allosteric activation of AMPK by phosphorylation of 172 threonine within alpha subunit of LKB1 complex in response to changes in cell energy or CAMKKβ, which activates intracellular Ca2+. The purpose was to study the activity of the main energy sensor of cells — AMPK in leukocytes in patients taking insulin preparations, metformin, and other hypoglycemic drugs in association with disease duration and glycated hemoglobin content. Materials and methods. The diabetic patients receiving single-drug or combined therapy with insulin and its analogues, metformin, dapagliflozin and sulfonylureas were randomized into 5 groups: the first group — with an HbA1c level close to the norm — 6.9–7.6 %; the second group — 7.6–9.0 %; the third group — > 9 %; the fourth group > 10 %; the fifth group — > 11 %. To determine the amount of phospho-AMPK (p-Thr172), ELISA kits were used. To get the calibration curve for the AMPK determination, a kidney cell culture HEK293T of the human embryonic kidney was used, which is recommended by manufacturer as a positive control. Results. It was shown that with increase of blood HbA1c, the level of AMPK activity in leukocytes gradually decreased. With increase of blood HbA1c, the level of AMPK activity in leukocytes gradually decreased. The activity of AMPK in leukocytes of patients with HbA1c > 11 % was more than 3.5-fold lower compared to the group with 6.9–7.6 % of HbA1c; AMPK activity in leukocytes in patients with disease duration of 20 years was 3-fold lower. Thus, the AMPK activity in leukocytes may be an indicator of diabetic compensation in diabetic patients. Conclusions. With increase of blood HbA1c, the level of p-AMPK in leukocytes gradually decreased. AMPK activity in leukocytes in diabetes patients with disease duration of 20 years was 3-fold lower than in patients with 10-year experience.
Authors and Affiliations
L. K. Sokolova, V. M. Pushkarev, Yu. B. Belchina, V. V. Pushkarev, T. S. Vatseba, N. D. Tronko
Keywords
Related Articles
- EP ID EP542441
- DOI 10.22141/2224-0721.15.1.2019.158688
- Views 60
- Downloads 0
Intraoperative cytology as an additional method for detecting papillary thyroid carcinoma
Background. Timely detection of papillary thyroid carcinoma (PTC) is very important, because the algorithm for patient’s treating depends on this. The main and effective method for preoperative diagnosis of PTC is a fine...
Role of Obesity in the Progression of Diabetic Nephropathy in Patients with Diabetes Mellitus (Literature Review)
The prevalence of obesity has risen proportionally to epidemic and continues to be a major health problem worldwide. The high prevalence of obesity is closely associated with the increased incidence of chronic diseases,...
Subclinical Hypercorticism: the Necessity of Diagnostic Search
Considering certain difficulties in subclinical hypercorticism diagnosis, the object of this work is to focus attention of doctors in different areas on the necessity of thorough examination of patients with pathological...
Melatonin in Genetic and Hormonal Regulation of Female Reproductive System Function
No abstract
Linguistic aspects of eponymic professional endocrinologic terminology
Background. Special linguistic researches of terminological units of different branches of medicine allow analyzing in details the ways of creating the systems of clinical terminology from different aspects: historical,...